CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

Tetrandrine 250mg  | ≥99%

CSNpharm

Tetrandrine, a bis-benzylisoquinoline alkaloid derived from Stephania tetrandra, is a calcium channel blocker that inhibits voltage-gated Ca2+ current (ICa) and Ca2+-activated K+ current.

More Information Supplier Page

Tetrandrine 100mg  | ≥99%

CSNpharm

Tetrandrine, a bis-benzylisoquinoline alkaloid derived from Stephania tetrandra, is a calcium channel blocker that inhibits voltage-gated Ca2+ current (ICa) and Ca2+-activated K+ current.

More Information Supplier Page

Tetrazolium Red 1g  | ≥99%

CSNpharm

Tetrazolium Red is a redox indicator used to visualize dehydrogenase enzyme activity and initially the tetrazolium solution is colorless but changes to red when it comes into contact with hydrogen.

More Information Supplier Page

TFEB activator 1 5mg  | ≥99%

CSNpharm

TFEB activator 1 is an orally effective, mTOR-independent activator of TFEB. It significantly promotes the nuclear translocation of Flag-TFEB with an EC50 of 2167 nM and enhances autophagy without inhibiting the mTOR pathway and has the potential for neurodegenerative diseases treatment. It also shows cytotoxic effect on HeLa, K562, MCF-​7 and MDA-​MB-​231 cancer cell lines.

More Information Supplier Page

TFEB activator 1 50mg  | ≥99%

CSNpharm

TFEB activator 1 is an orally effective, mTOR-independent activator of TFEB. It significantly promotes the nuclear translocation of Flag-TFEB with an EC50 of 2167 nM and enhances autophagy without inhibiting the mTOR pathway and has the potential for neurodegenerative diseases treatment. It also shows cytotoxic effect on HeLa, K562, MCF-​7 and MDA-​MB-​231 cancer cell lines.

More Information Supplier Page

TFEB activator 1 10mg  | ≥99%

CSNpharm

TFEB activator 1 is an orally effective, mTOR-independent activator of TFEB. It significantly promotes the nuclear translocation of Flag-TFEB with an EC50 of 2167 nM and enhances autophagy without inhibiting the mTOR pathway and has the potential for neurodegenerative diseases treatment. It also shows cytotoxic effect on HeLa, K562, MCF-​7 and MDA-​MB-​231 cancer cell lines.

More Information Supplier Page

TFEB activator 1 100mg  | ≥99%

CSNpharm

TFEB activator 1 is an orally effective, mTOR-independent activator of TFEB. It significantly promotes the nuclear translocation of Flag-TFEB with an EC50 of 2167 nM and enhances autophagy without inhibiting the mTOR pathway and has the potential for neurodegenerative diseases treatment. It also shows cytotoxic effect on HeLa, K562, MCF-​7 and MDA-​MB-​231 cancer cell lines.

More Information Supplier Page

TG 101348 25mg  | ≥98%

CSNpharm

TG 101348 is an inhibitor of JAK2 with an IC₅₀ of 6 nM and also inhibits related kinases FLT3, RET, and JAK3 with less potent activity, having IC₅₀ values of 25, 17 and 169 nM, respectively.

More Information Supplier Page

TG 101348 50mg  | ≥98%

CSNpharm

TG 101348 is an inhibitor of JAK2 with an IC₅₀ of 6 nM and also inhibits related kinases FLT3, RET, and JAK3 with less potent activity, having IC₅₀ values of 25, 17 and 169 nM, respectively.

More Information Supplier Page

TG 101348 100mg  | ≥98%

CSNpharm

TG 101348 is an inhibitor of JAK2 with an IC₅₀ of 6 nM and also inhibits related kinases FLT3, RET, and JAK3 with less potent activity, having IC₅₀ values of 25, 17 and 169 nM, respectively.

More Information Supplier Page

TG 101348 10mg  | ≥98%

CSNpharm

TG 101348 is an inhibitor of JAK2 with an IC₅₀ of 6 nM and also inhibits related kinases FLT3, RET, and JAK3 with less potent activity, having IC₅₀ values of 25, 17 and 169 nM, respectively.

More Information Supplier Page

TG 101348 5mg  | ≥98%

CSNpharm

TG 101348 is an inhibitor of JAK2 with an IC₅₀ of 6 nM and also inhibits related kinases FLT3, RET, and JAK3 with less potent activity, having IC₅₀ values of 25, 17 and 169 nM, respectively.

More Information Supplier Page

TG693 1g  | ≥95%

CSNpharm

TG693, an orally available inhibitor of CLK1, promotes the skipping of the endogenous mutated exon 31 in Duchenne muscular dystrophy (DMD) patient-derived cells and increased the production of the functional exon 31-skipped dystrophin protein.

More Information Supplier Page

TGR5 Receptor Agonist 10mg  | ≥98%

CSNpharm

TGR5 receptor agonist, a potent TGR5 (GPCR19) agonist, showed improved potency in the U2-OS cell assay (pEC50 = 6.8) and in melanophore cells (pEC50 = 7.5).

More Information Supplier Page

TGR5 Receptor Agonist 25mg  | ≥98%

CSNpharm

TGR5 receptor agonist, a potent TGR5 (GPCR19) agonist, showed improved potency in the U2-OS cell assay (pEC50 = 6.8) and in melanophore cells (pEC50 = 7.5).

More Information Supplier Page

TGR5 Receptor Agonist 50mg  | ≥98%

CSNpharm

TGR5 receptor agonist, a potent TGR5 (GPCR19) agonist, showed improved potency in the U2-OS cell assay (pEC50 = 6.8) and in melanophore cells (pEC50 = 7.5).

More Information Supplier Page

TGR5 Receptor Agonist 1mg  | ≥98%

CSNpharm

TGR5 receptor agonist, a potent TGR5 (GPCR19) agonist, showed improved potency in the U2-OS cell assay (pEC50 = 6.8) and in melanophore cells (pEC50 = 7.5).

More Information Supplier Page

TGR5 Receptor Agonist 100mg  | ≥98%

CSNpharm

TGR5 receptor agonist, a potent TGR5 (GPCR19) agonist, showed improved potency in the U2-OS cell assay (pEC50 = 6.8) and in melanophore cells (pEC50 = 7.5).

More Information Supplier Page

TGR5 Receptor Agonist 5mg  | ≥98%

CSNpharm

TGR5 receptor agonist, a potent TGR5 (GPCR19) agonist, showed improved potency in the U2-OS cell assay (pEC50 = 6.8) and in melanophore cells (pEC50 = 7.5).

More Information Supplier Page

TH 1020 50mg  | ≥98%

CSNpharm

TH1020 is Toll-like receptor (TLR) 5/Flagellin complex antagonist with IC50 of 0.85 μM. TH1020 competes with flagellin for TLR5 binding to inhibit the TLR5:flagellin interaction and subsequent downstream TNF-α secretion.

More Information Supplier Page

TH 1020 10mg  | ≥98%

CSNpharm

TH1020 is Toll-like receptor (TLR) 5/Flagellin complex antagonist with IC50 of 0.85 μM. TH1020 competes with flagellin for TLR5 binding to inhibit the TLR5:flagellin interaction and subsequent downstream TNF-α secretion.

More Information Supplier Page

TH 1020 5mg  | ≥98%

CSNpharm

TH1020 is Toll-like receptor (TLR) 5/Flagellin complex antagonist with IC50 of 0.85 μM. TH1020 competes with flagellin for TLR5 binding to inhibit the TLR5:flagellin interaction and subsequent downstream TNF-α secretion.

More Information Supplier Page

TH 1020 25mg  | ≥98%

CSNpharm

TH1020 is Toll-like receptor (TLR) 5/Flagellin complex antagonist with IC50 of 0.85 μM. TH1020 competes with flagellin for TLR5 binding to inhibit the TLR5:flagellin interaction and subsequent downstream TNF-α secretion.

More Information Supplier Page

TH 257 100mg  | ≥98%

CSNpharm

TH-257 is a selective LIMK inhibitor with IC50 values of 84nM and 39nM for LIMK1 and LIMK2, respectively.

More Information Supplier Page

TH 257 50mg  | ≥98%

CSNpharm

TH-257 is a selective LIMK inhibitor with IC50 values of 84nM and 39nM for LIMK1 and LIMK2, respectively.

More Information Supplier Page

TH 257 10mg  | ≥98%

CSNpharm

TH-257 is a selective LIMK inhibitor with IC50 values of 84nM and 39nM for LIMK1 and LIMK2, respectively.

More Information Supplier Page

TH 257 25mg  | ≥98%

CSNpharm

TH-257 is a selective LIMK inhibitor with IC50 values of 84nM and 39nM for LIMK1 and LIMK2, respectively.

More Information Supplier Page

TH 257 5mg  | ≥98%

CSNpharm

TH-257 is a selective LIMK inhibitor with IC50 values of 84nM and 39nM for LIMK1 and LIMK2, respectively.

More Information Supplier Page

TH34 25mg  | ≥98%

CSNpharm

TH34 is a potent HDAC6/8/10 inhibitor that induces DNA damage-mediated cell death in human high-grade neuroblastoma cell lines.

More Information Supplier Page

TH34 50mg  | ≥98%

CSNpharm

TH34 is a potent HDAC6/8/10 inhibitor that induces DNA damage-mediated cell death in human high-grade neuroblastoma cell lines.

More Information Supplier Page

TH34 10mg  | ≥98%

CSNpharm

TH34 is a potent HDAC6/8/10 inhibitor that induces DNA damage-mediated cell death in human high-grade neuroblastoma cell lines.

More Information Supplier Page

TH34 5mg  | ≥98%

CSNpharm

TH34 is a potent HDAC6/8/10 inhibitor that induces DNA damage-mediated cell death in human high-grade neuroblastoma cell lines.

More Information Supplier Page

Thalidomide 250mg  | ≥99%

CSNpharm

Thalidomide targets to CRBN with IC50 of 8.5 nM. It can inhibit biosynthesis of TNF-α and has anti-angiogenic and immunosuppressive effects.

More Information Supplier Page

Theaflavin 10mg  | ≥98%

CSNpharm

Theaflavin, a type of thearubigins, exhibits inhibition of xanthine oxidase enzyme and can scavenge various oxidation radicals with anti-oxidant and anti-tumor activities. It can be purified from the leaves of Camellia sinensis (L.) O. Kuntze.

More Information Supplier Page

Theaflavin 5mg  | ≥98%

CSNpharm

Theaflavin, a type of thearubigins, exhibits inhibition of xanthine oxidase enzyme and can scavenge various oxidation radicals with anti-oxidant and anti-tumor activities. It can be purified from the leaves of Camellia sinensis (L.) O. Kuntze.

More Information Supplier Page

Theaflavin 2mg  | ≥98%

CSNpharm

Theaflavin, a type of thearubigins, exhibits inhibition of xanthine oxidase enzyme and can scavenge various oxidation radicals with anti-oxidant and anti-tumor activities. It can be purified from the leaves of Camellia sinensis (L.) O. Kuntze.

More Information Supplier Page

Theaflavin 25mg  | ≥98%

CSNpharm

Theaflavin, a type of thearubigins, exhibits inhibition of xanthine oxidase enzyme and can scavenge various oxidation radicals with anti-oxidant and anti-tumor activities. It can be purified from the leaves of Camellia sinensis (L.) O. Kuntze.

More Information Supplier Page